A Phase 1 Study of NM6603 in Advanced Solid Tumors

Recruiting

Phase 1

NM6603A Phase 1 Study of NM6603 in Advanced Solid Tumors

Sponsor:

NucMito Pharmaceuticals Co. Ltd.

Code:

NCT06046066

Conditions

Cancers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NM6603

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-05. This information was provided to ClinicalTrials.gov by NucMito Pharmaceuticals Co. Ltd. on 2025-06-12.